What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic?

See allHide authors and affiliations

Science Translational Medicine  14 Nov 2012:
Vol. 4, Issue 160, pp. 160cm14
DOI: 10.1126/scitranslmed.3004915

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article